Capstone (CAPS) vs Ernexa Therapeutics (ERNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Ernexa Therapeutics is the larger company by market cap ($4.1 million vs $3.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAPS | ERNA |
|---|---|---|
| Share price | $0.1409 | $2.49 |
| Market cap | $3.72M | $4.06M |
| 1-day change | +0.57% | +4.18% |
| EPS (TTM) | $-3.32 | $-13.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.36 | $71.50 |
| 52-week low | $0.13 | $2.14 |
| Distance from 52-week high | -89.64% | -96.52% |
| Analyst consensus | none | none |
| Avg. price target upside | +2029.17% | +1104.82% |
| Average volume | 4.35M | 472.81K |
| Shares outstanding | 26.38M | 1.63M |
| Employees | 93 | 5 |
| Sector | Basic Materials | Healthcare |
| Industry | Building Materials | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Capstone in Basic Materials and Ernexa Therapeutics in Healthcare.
About Capstone
CAPS stock →Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.
Basic Materials · Building Materials · 93 employees
About Ernexa Therapeutics
ERNA stock →Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis.
Healthcare · Biotechnology · 5 employees
CAPS vs ERNA FAQ
Which is bigger, Capstone or Ernexa Therapeutics?
Ernexa Therapeutics (ERNA) is larger, with a market capitalization of $4.06M compared with $3.72M for Capstone (CAPS).
Are Capstone and Ernexa Therapeutics in the same industry?
No. Capstone is in the Basic Materials sector, while Ernexa Therapeutics is in Healthcare.